These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 27028919
1. Postmenopausal Hormone Therapy and Atherosclerosis--Time Is of the Essence. Keaney JF, Solomon CG. N Engl J Med; 2016 Mar 31; 374(13):1279-80. PubMed ID: 27028919 [No Abstract] [Full Text] [Related]
2. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. Hodis HN, Mack WJ, Henderson VW, Shoupe D, Budoff MJ, Hwang-Levine J, Li Y, Feng M, Dustin L, Kono N, Stanczyk FZ, Selzer RH, Azen SP, ELITE Research Group. N Engl J Med; 2016 Mar 31; 374(13):1221-31. PubMed ID: 27028912 [Abstract] [Full Text] [Related]
3. Hormone replacement therapy and atherosclerosis in postmenopausal women: does aging limit therapeutic benefits? Barton M, Meyer MR, Haas E. Arterioscler Thromb Vasc Biol; 2007 Aug 31; 27(8):1669-72. PubMed ID: 17634518 [No Abstract] [Full Text] [Related]
4. Summaries for patients. Hormone treatment beginning near the onset of menopause. Ann Intern Med; 2014 Aug 19; 161(4):I-19. PubMed ID: 25069612 [No Abstract] [Full Text] [Related]
5. Differential Effect of Plasma Estradiol on Subclinical Atherosclerosis Progression in Early vs Late Postmenopause. Sriprasert I, Hodis HN, Karim R, Stanczyk FZ, Shoupe D, Henderson VW, Mack WJ. J Clin Endocrinol Metab; 2019 Feb 01; 104(2):293-300. PubMed ID: 30272234 [Abstract] [Full Text] [Related]
6. The hope for KEEPS. Lobo RA. Climacteric; 2015 Apr 01; 18(2):108-9. PubMed ID: 25651981 [No Abstract] [Full Text] [Related]
8. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Harman SM, Black DM, Naftolin F, Brinton EA, Budoff MJ, Cedars MI, Hopkins PN, Lobo RA, Manson JE, Merriam GR, Miller VM, Neal-Perry G, Santoro N, Taylor HS, Vittinghoff E, Yan M, Hodis HN. Ann Intern Med; 2014 Aug 19; 161(4):249-60. PubMed ID: 25069991 [Abstract] [Full Text] [Related]
9. New evidence for cardiac benefit of postmenopausal hormone therapy. Mikkola TS, Savolainen-Peltonen H, Venetkoski M, Ylikorkala O. Climacteric; 2017 Feb 19; 20(1):5-10. PubMed ID: 28042727 [Abstract] [Full Text] [Related]
10. Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis. Hodis HN, Mack WJ, Shoupe D, Azen SP, Stanczyk FZ, Hwang-Levine J, Budoff MJ, Henderson VW. Menopause; 2015 Apr 19; 22(4):391-401. PubMed ID: 25380275 [Abstract] [Full Text] [Related]
11. Tamoxifen improves endothelial function and reduces carotid intima-media thickness in postmenopausal women. Stamatelopoulos KS, Lekakis JP, Poulakaki NA, Papamichael CM, Venetsanou K, Aznaouridis K, Protogerou AD, Papaioannou TG, Kumar S, Stamatelopoulos SF. Am Heart J; 2004 Jun 19; 147(6):1093-9. PubMed ID: 15199361 [Abstract] [Full Text] [Related]
12. Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial. Steiner AZ, Hodis HN, Lobo RA, Shoupe D, Xiang M, Mack WJ. Menopause; 2005 Jun 19; 12(6):728-33. PubMed ID: 16278616 [Abstract] [Full Text] [Related]
13. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause]. Rachev E. Akush Ginekol (Sofiia); 1994 Jun 19; 33(3):45-7. PubMed ID: 7793531 [Abstract] [Full Text] [Related]
14. Subclinical cardiovascular disease in postmenopausal women with low/medium cardiovascular risk by the Framingham risk score. Maturana MA, Franz RF, Metzdorf M, da Silva TR, Spritzer PM. Maturitas; 2015 Jun 19; 81(2):311-6. PubMed ID: 25869902 [Abstract] [Full Text] [Related]
15. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. Hodis HN, Mack WJ, Azen SP, Lobo RA, Shoupe D, Mahrer PR, Faxon DP, Cashin-Hemphill L, Sanmarco ME, French WJ, Shook TL, Gaarder TD, Mehra AO, Rabbani R, Sevanian A, Shil AB, Torres M, Vogelbach KH, Selzer RH, Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial Research Group. N Engl J Med; 2003 Aug 07; 349(6):535-45. PubMed ID: 12904518 [Abstract] [Full Text] [Related]
16. Low-dose rosuvastatin improves the functional and morphological markers of atherosclerosis in asymptomatic postmenopausal women with dyslipidemia. Igase M, Kohara K, Tabara Y, Nagai T, Ochi N, Kido T, Ochi M, Miki T. Menopause; 2012 Dec 07; 19(12):1294-9. PubMed ID: 22850442 [Abstract] [Full Text] [Related]
17. Effect of transdermal hormone replacement therapy on carotid artery wall thickness and levels of vascular inflammatory markers in postmenopausal women. Sumino H, Ichikawa S, Kasama S, Kumakura H, Takayama Y, Sakamaki T, Kurabayashi M. Hypertens Res; 2005 Jul 07; 28(7):579-84. PubMed ID: 16335886 [Abstract] [Full Text] [Related]
18. Long-term effect of estrogen replacement on plasma nitric oxide levels: results from the estrogen in the prevention of atherosclerosis trial (EPAT). Hwang J, Mack WJ, Xiang M, Sevanian A, Lobo RA, Hodis HN. Atherosclerosis; 2005 Aug 07; 181(2):375-80. PubMed ID: 16039293 [Abstract] [Full Text] [Related]
19. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease. Yeboah J, Klein K, Brosnihan B, Reboussin D, Herrington DM. Menopause; 2008 Aug 07; 15(6):1060-4. PubMed ID: 18521047 [Abstract] [Full Text] [Related]